This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2i9b
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:2i9b. | + | {{Seed}} |
| + | [[Image:2i9b.png|left|200px]] | ||
<!-- | <!-- | ||
| Line 9: | Line 10: | ||
{{STRUCTURE_2i9b| PDB=2i9b | SCENE= }} | {{STRUCTURE_2i9b| PDB=2i9b | SCENE= }} | ||
| - | + | ===Crystal structure of ATF-urokinase receptor complex=== | |
| - | + | <!-- | |
| - | + | The line below this paragraph, {{ABSTRACT_PUBMED_16979660}}, adds the Publication Abstract to the page | |
| + | (as it appears on PubMed at http://www.pubmed.gov), where 16979660 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_16979660}} | ||
==Disease== | ==Disease== | ||
| Line 31: | Line 35: | ||
[[Category: Kringle domain]] | [[Category: Kringle domain]] | ||
[[Category: Urokinase receptor]] | [[Category: Urokinase receptor]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 01:35:16 2008'' | ||
Revision as of 22:35, 27 July 2008
Contents |
Crystal structure of ATF-urokinase receptor complex
Template:ABSTRACT PUBMED 16979660
Disease
Known disease associated with this structure: Alzheimer disease, late-onset, susceptibility to OMIM:[191840]
About this Structure
2I9B is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structural basis of interaction between urokinase-type plasminogen activator and its receptor., Barinka C, Parry G, Callahan J, Shaw DE, Kuo A, Bdeir K, Cines DB, Mazar A, Lubkowski J, J Mol Biol. 2006 Oct 20;363(2):482-95. Epub 2006 Aug 26. PMID:16979660
Page seeded by OCA on Mon Jul 28 01:35:16 2008
